April 27, 2020 07:05 AM EDTUpdated 10:43 AM

#AACR20: Iovance revels in promising lung cancer data out of Moffitt as TIL therapy triggers 2 complete responses

Shrinking, or even eradicating, solid tumors has been a Holy Grail for cell therapies, whose effects so far have been limited to blood cancers. At …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

#AACR20: Io­vance rev­els in promis­ing lung can­cer da­ta out of Mof­fitt as TIL ther­a­py trig­gers 2 com­plete re­spons­es